Announced details
Economic losses caused by myopia in Japan, labor productivity, and myopia prevention policy
The median annual economic loss attributable to myopia in Japan is approximately ¥4.0 trillion (95% credible interval: ¥1.7 trillion to ¥8.3 trillion), with a deterministic base case of ¥4.3 trillion, equivalent to 0.64% of GDP. Approximately 77% of the loss is attributable to lower labor productivity. Annual losses in 2050 are estimated at ¥5.0 trillion to ¥10.7 trillion
Publication of a paper by Ryo Kubota (窪田 良), Representative Director, Chairman, President and CEO of Kubota Pharmaceutical Holdings Co., Ltd. The company paid the paper's publication fee
International academic journal. Location, representative, capital, year established and other details are not disclosed
Published as a peer-reviewed paper
Journal of Global Health Economics and Policy
DOI: 10.7189/001c.167428. Publication information: 2026;6:e2026035. Expiry date is not disclosed
Does not indicate the outlook for the company's performance, product performance or regulatory outcomes
The company does not address Contract Value / Offering price.
Peer-reviewed paper published in the Journal of Global Health Economics and Policy. Title: Myopia-attributable economic burden in Japan: a cost-of-illness modelling study with probabilistic sensitivity analysis and projection to 2050. The source code and all parameters for the Monte Carlo simulation have been made publicly available
| Item | Details |
|---|---|
| Counterparty | Journal of Global Health Economics and Policy (publication) |
| Counterparty overview | International academic journal. Location, representative, capital, year established and other details are not disclosed |
| Relationship with the Company | Publication of a paper by Ryo Kubota (窪田 良), Representative Director, Chairman, President and CEO of Kubota Pharmaceutical Holdings Co., Ltd. The company paid the paper's publication fee |
| Launch date | 11 September 2026 (date the paper's publication was announced; the paper's actual publication date is not disclosed) |
| Applicable area | Economic losses caused by myopia in Japan, labor productivity, and myopia prevention policy |
| Award/certification name | Published as a peer-reviewed paper |
| Awarding / certifying body | Journal of Global Health Economics and Policy |
| Registration number and expiry date | DOI: 10.7189/001c.167428. Publication information: 2026;6:e2026035. Expiry date is not disclosed |
| Quantitative Effects | The median annual economic loss attributable to myopia in Japan is approximately ¥4.0 trillion (95% credible interval: ¥1.7 trillion to ¥8.3 trillion), with a deterministic base case of ¥4.3 trillion, equivalent to 0.64% of GDP. Approximately 77% of the loss is attributable to lower labor productivity. Annual losses in 2050 are estimated at ¥5.0 trillion to ¥10.7 trillion |
| Impact on Business Performance | Does not indicate the outlook for the company's performance, product performance or regulatory outcomes |
| Source | Peer-reviewed paper published in the Journal of Global Health Economics and Policy. Title: Myopia-attributable economic burden in Japan: a cost-of-illness modelling study with probabilistic sensitivity analysis and projection to 2050. The source code and all parameters for the Monte Carlo simulation have been made publicly available |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To estimate the economic losses attributable to myopia, including its impact on the labor productivity of workers. The company explains that the paper provides an economic basis for promoting myopia prevention among children as a national policy and academic support for policy recommendations.